`___________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`___________
`
`COALITION FOR AFFORDABLE DRUGS V LLC,
`Petitioner,
`
`v.
`
`BIOGEN MA INC.,
`Patent Owner.
`____________________________________________
`
`Case: IPR2015-01136
`U.S. Patent No. 8,399,514
`
`____________________________________________
`
`
`
`PATENT OWNER’S SUPPLEMENTAL MANDATORY NOTICE
`
`
`
`
`
`
`
`
`Patent Owner’s Supplemental Mandatory Notice
`Case No. IPR2015-01136
`
`
`Pursuant to 37 C.F.R. § 42.8 (a)(3), Patent Owner Biogen MA Inc. submits
`
`the following Supplemental Mandatory Notice providing an update on the status of
`
`the Related Matters.
`
`I. Real Party-in-Interest - 37 C.F.R. § 42.8(b)(1)
`
`The real party-in-interest is Biogen MA Inc., the owner of U.S. Patent No.
`
`8,399,514. A corporate name change document was recorded in the U.S. Patent
`
`and Trademark Office on April 27, 2015 (reel 35507/frame 541) and May 4, 2015
`
`(reel 35571/frame 926). Those documents changed the corporate name from
`
`Biogen Idec MA Inc. to Biogen MA Inc. The original assignment to Biogen Idec
`
`MA Inc. of U.S. patent application No. 13/372,426 that led to U.S. Patent No.
`
`8,399,514 was recorded in the Office on May 3, 2012, at reel 28146, frame 980.
`
`II. Related Matters - 37 C.F.R. § 42.8(b)(2)
`
`Interference No. 106,023 (McK), involving U.S. Patent No. 8,399,514, was
`
`declared between Biogen MA Inc. and Forward Pharma A/S on April 13, 2015.
`
`The petition incorrectly states that the interference was declared in 2005. U.S.
`
`Application Nos. 13/767,014 (abandoned), 13/804,283 (pending), and 14/718,962
`
`(pending), claim benefit of priority to the application that issued as U.S. Patent No.
`
`8,399,514. Patent Owner is not aware of any other related matters that would affect
`
`or be affected by this proceeding.
`
`
`
`2
`
`
`
`Patent Owner’s Supplemental Mandatory Notice
`Case No. IPR2015-01136
`III. Lead and Back-up Counsel - 37 C.F.R. § 42.8(b)(3)
`
`Lead Counsel: Michael J. Flibbert (Reg. No. 33,234); Tel: 202.408.4493
`
`Backup Counsel: Maureen D. Queler (Reg. No. 61,879); Tel: 202.408.4294
`
`Address: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, 901 New York
`
`Avenue, NW, Washington, DC 20001. FAX: 202-408-4000
`
`A power of attorney from Biogen MA Inc. to Finnegan, Henderson,
`
`Farabow, Garrett & Dunner, LLP (Customer Number 22,852) was filed on May
`
`22, 2015, in compliance with 37 C.F.R. § 42.10(b).
`
`IV. Service Information
`
`
`
`Please send all correspondence to the lead counsel at the address shown
`
`above. Under 37 C.F.R. § 42.6(e), Patent Owner consents to electronic service by
`
`email at michael.flibbert@finnegan.com and maureen.queler@finnegan.com.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`
`By: /Maureen D. Queler/
`Michael J. Flibbert, Reg. No. 33,234
`Maureen D. Queler, Reg. No. 61,879
`Finnegan, Henderson, Farabow, Garrett
`
`& Dunner, LLP
`901 New York Avenue, NW
`Washington, DC 20001-4413
`(202) 408-4000
`
`Counsel for Patent Owner
`
`
`
`3
`
`
`
`Dated: July 29, 2015
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing Patent
`
`Owner’s Supplemental Mandatory Notice was served electronically via e-mail
`
`on July 29, 2015, in its entirety on the following:
`
`Robert W. Hahl
`Neifeld IP Law, PC, 4813-B
`Eisenhower Avenue, Alexandria, VA 22304
`rhahl@neifeld.com
`
`Robert Mihail
`Neifeld IP Law, PC, 4813-B
`Eisenhower Avenue, Alexandria, VA 22304
`rmihail@neifeld.com
`
`Petitioner has agreed to electronic service.
`
`Dated: July 29, 2015
`
`
`
`
`
`By: /Maureen D. Queler/
`Maureen D. Queler
`
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, LLP